Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vial

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Molecular and Biochemical Parasitology|February 1, 1991
Distinct lipid compositions of parasite and host cell plasma membranes from Plasmodium chabaudi-infected erythrocytesF Wunderlich, S Fiebig, H Vial, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 1, 1997
Removing rater effects from medical clerkship evaluationsW P Fisher, R H Vial, C V Sanders
The Medical Journal of Australia|December 5, 1988
Hazards of urinary alkalizing agentsT C Beard, S J Wilkinson, J H Vial
Journal of Hypertension|February 1, 1989
Structural change in the rat hindlimb during deoxycorticosterone acetate hypertension; its reversibility and preventionJ H Vial, A C Yong, G W Boyd
Clinical and Experimental Pharmacology & Physiology|December 1, 1991
Delayed recovery from NG-nitro-L-arginine in the conscious sheepC K Narkowicz, J H Vial, X F Xu
The Annals of Pharmacotherapy|September 30, 2004
A community-based educational intervention to improve antithrombotic drug use in atrial fibrillationShane L Jackson, Gregory M Peterson, Janet H Vial
Free Radical Research Communications|January 1, 1993
Hyperbaric oxygen therapy increases free radical levels in the blood of humansC K Narkowicz, J H Vial, P W McCartney
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
Onset and offset of structural arteriolar changes in DOCA/salt hypertension in the ratJ H Vial, A C Yong, G W Boyd
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawalJ H Vial, L J McLeod, M S Roberts
Clinical and Experimental Pharmacology & Physiology|May 1, 1983
Prevention of structural arteriolar changes in DOCA hypertension with hydrallazineJ H Vial, A C Yong, G W Boyd
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Molecular and Biochemical Parasitology|February 1, 1991
Distinct lipid compositions of parasite and host cell plasma membranes from Plasmodium chabaudi-infected erythrocytesF Wunderlich, S Fiebig, H Vial, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 1, 1997
Removing rater effects from medical clerkship evaluationsW P Fisher, R H Vial, C V Sanders
The Medical Journal of Australia|December 5, 1988
Hazards of urinary alkalizing agentsT C Beard, S J Wilkinson, J H Vial
Journal of Hypertension|February 1, 1989
Structural change in the rat hindlimb during deoxycorticosterone acetate hypertension; its reversibility and preventionJ H Vial, A C Yong, G W Boyd
Clinical and Experimental Pharmacology & Physiology|December 1, 1991
Delayed recovery from NG-nitro-L-arginine in the conscious sheepC K Narkowicz, J H Vial, X F Xu
The Annals of Pharmacotherapy|September 30, 2004
A community-based educational intervention to improve antithrombotic drug use in atrial fibrillationShane L Jackson, Gregory M Peterson, Janet H Vial
Free Radical Research Communications|January 1, 1993
Hyperbaric oxygen therapy increases free radical levels in the blood of humansC K Narkowicz, J H Vial, P W McCartney
Clinical and Experimental Pharmacology & Physiology|May 1, 1982
Onset and offset of structural arteriolar changes in DOCA/salt hypertension in the ratJ H Vial, A C Yong, G W Boyd
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawalJ H Vial, L J McLeod, M S Roberts
Clinical and Experimental Pharmacology & Physiology|May 1, 1983
Prevention of structural arteriolar changes in DOCA hypertension with hydrallazineJ H Vial, A C Yong, G W Boyd
Pageof 6